A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE3
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
- Status
- TERMINATED
- Phase
- PHASE2
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
- Status
- COMPLETED
- Phase
- NA
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE2
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- N/A
Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients
- Status
- UNKNOWN
- Phase
- PHASE4
Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
- Status
- UNKNOWN
- Phase
- PHASE4
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2